Guilin Sanjin Pharmaceutical (002275.SZ): The actual controller and chairman of the company has completed the shareholding plan, with a cumulative shareholding of 0.383 million shares.

Gelonghui Finance · Sep 2 15:58

On September 2, Guilin Sanjin Pharmaceutical (002275.SZ) announced that on March 2, 2024, the company disclosed the Announcement on the Plan of the Actual Controller, Chairman and CEO to Increase Shareholding of the Company. Mr. Zou Xun, the actual controller, chairman and CEO of the company, plans to increase the company's shares through the Shenzhen Stock Exchange through centralized bidding or block trade within six months starting from March 2, 2024, using his own funds, with the amount of shareholding not less than 5 million yuan.

From March 2, 2024 to September 1, 2024, Mr. Zou Xun increased the company's shares by a total of 383,000 shares through centralized bidding on the Shenzhen Stock Exchange, accounting for 0.07% of the company's total share capital, with a total shareholding amount of 5.0458 million yuan. This shareholding plan has been successfully completed.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

桂林三金(002275.SZ)：公司实际控制人、董事长增持计划完成 累计增持38.3万股

Guilin Sanjin Pharmaceutical (002275.SZ): The actual controller and chairman of the company has completed the shareholding plan, with a cumulative shareholding of 0.383 million shares.

Risk Disclaimer

Statement

桂林三金(002275.SZ)：公司实际控制人、董事长增持计划完成累计增持38.3万股